Drawing for CROWDPHARM

USPTO serial 87360068

CROWDPHARM

Reviewed by CopyMark Law Group

Reg. 5623349Status 702Registered
Filing date
Status date
Registration date
Dec 4, 2018
Examiner
BLANDU, FLORENTINA
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with CROWDPHARM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
042Computer services, namely, providing and maintaining websites and technology platforms featuring an online, non-downloadable application that enables businesses to request product development ideas, strategic or directional recommendations, scripts, designs, content and proposals from a community of members to generate answers or solutions in the pharmaceutical industry; Computer services, namely, providing and maintaining websites and technology platforms featuring an online, non-downloadable application that enables businesses to request product development ideas, strategic or directional recommendations, scripts, designs, content and proposals from a community of members to generate answers or solutions in the healthcare industry; online non-downloadable application that matriculates members, provides terms of submission and non-disclosure agreements, posts queries, enables user-generated creative content and, generates a compilation of the submissions for delivery to and review by clients in the pharmaceutical industry; online non-downloadable application that matriculates members, provides terms of submission and non-disclosure agreements, posts queries, enables user-generated creative content and, generates a compilation of the submissions for delivery to and review by clients in the healthcare industry; computer services, namely, creating an online community for registered users to participate in developing product development ideas, strategic or directional recommendations, scripts, designs, and content in the pharmaceutical industry; computer services, namely, creating an online community for registered users to participate in developing product development ideas, strategic or directional recommendations, scripts, designs, and content in the healthcare industry; application service provider, namely, providing, managing, developing, and maintaining applications, websites, and platforms in the fields of scheduling, tracking and fulfilling requests for the performance of business consulting projects in the pharmaceutical industry; application service provider, namely, providing, managing, developing, and maintaining applications, websites, and platforms in the fields of scheduling, tracking and fulfilling requests for the performance of business consulting projects in the healthcare industry; computer services, namely, maintaining websites and technology platforms featuring online, non-downloadable applications that enable users to create, post, share and disseminate user-generated multimedia content in the pharmaceutical industry; computer services, namely, maintaining websites and technology platforms featuring online, non-downloadable applications that enable users to create, post, share and disseminate user-generated multimedia content in the healthcare industry; providing temporary use of on-line non-downloadable application that enable users to collaborate in the creation, dissemination and selection of multimedia content in the pharmaceutical industry; providing temporary use of on-line non-downloadable application that enable users to collaborate in the creation, dissemination and selection of multimedia content in the healthcare industryACTIVEJun 26, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 13, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 13, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 13, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 13, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 13, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 10, 2024NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jun 10, 2024C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jun 10, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 4, 2023E815TEAS SECTION 8 & 15 RECEIVED
Dec 4, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 23, 2022ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 4, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 1, 2018SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 31, 2018CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 3, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Oct 3, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2018ALIEASSIGNED TO LIE
Sep 20, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 9, 2018DOCKASSIGNED TO EXAMINER
Apr 18, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 18, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 18, 2018CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 27, 2018SUPCSTATEMENT OF USE PROCESSING COMPLETE
Mar 21, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 6, 2018IUAFUSE AMENDMENT FILED
Mar 6, 2018EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Sep 12, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 18, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 18, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 28, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 5, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 30, 2017DOCKASSIGNED TO EXAMINER
Mar 11, 2017MPMKNOTICE OF PSEUDO MARK E-MAILED
Mar 10, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 9, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance